Abstract
Background and Aim
Severe acute pancreatitis (SAP) is commonly associated with intra‐abdominal hypertension (IAH). This acute increase of intra‐abdominal pressure (IAP) may be attributed to early organ dysfunction, leading to an increased morbidity and mortality. To assess the incidence of raised IAH and its correlation with other prognostic indicators and various outcomes in SAP.
Methods and Results
This was a prospective observational study in patients of SAP between July 2009 and December 2010. All patients of SAP who were admitted to the hospital within 2 weeks of onset of pain were included in the study. A total of 35 patients with SAP were included in the study. Among these, 25 (71.4%) were males. All our patients had raised IAP; however, IAH was present in 51.4% (18/35). Patients with IAH were found to have a higher APACHE II score (88.9 vs 5.9%; P < 0.001), infectious complications (72.2 vs 5.9%; P < 0.001), circulatory failure (88.9 vs 0%; P < 0.001), and respiratory failure (100 vs 41.2%; P < 0.001). All the eight (22.8%) patients who succumbed to sepsis had IAH. Patients with IAH were found to have a significantly longer intensive care unit (ICU) stay (17.72 vs 12.29 days) and in‐hospital stay (24.89 vs 12.29 days).
Conclusion
IAH is a good negative prognostic marker in SAP, seen in up to 51.4%. IAH was found to have a significant negative impact on the outcome in terms of increased mortality, morbidity, in‐hospital stay, and ICU stay among the patients of SAP.
Keywords: intra‐abdominal hypertension, intra‐abdominal pressure, prognostic marker, severe acute pancreatitis
This study has proven the correlation of raised intra‐abdominal pressure in severe acute pancreatitis with poor outcome. Hence, serial monitoring of intra‐abdominal pressure in severe acute pancreatitis should be performed, and appropriate measures should be taken when it is present.
Introduction
Severe acute pancreatitis (SAP) is a potentially life‐threatening disease and accounts for 20% of all pancreatitis. 1 Overall mortality of acute pancreatitis (AP) is around 5%; however, it can reach up to 20–30% in SAP. The mortality of infected necrosis ranges from 47 to 69% among patients who develop multiorgan dysfunction syndrome (MODS). 2 , 3 , 4 , 5 , 6
Mortality in AP has a bimodal peak. About 50% of patients die within first 2 weeks following a sequalae of inflammatory mediators leading to MODS. This disease is caused by excessive leukocyte activation, leading to the release of secondary inflammatory mediators [Interleukins (IL) ‐ IL‐1α, IL‐6, IL‐8, IL‐10, tumour necrosis factor (TNF‐α), platelet‐activating factor, nitric oxide (NO), arachidonic acid metabolites], resulting in massive inflammatory response, contributing to the induction of systemic inflammatory response syndrome (SIRS). Mortality after 2 weeks is usually due to septic complications. 7 , 8 , 9 , 10 , 11 , 12
Evidence suggests that, in addition to SIRS, untreated abdominal compartment syndrome (ACS) is one of the contributing factors to mortality in the early phase of SAP. Intra‐abdominal pressure (IAP) ranges between 0 and 5 mm of Hg and varies with the respiratory cycle. 13 , 14 According to the World Society on Abdominal Compartment Syndrome (WSACS), intra‐abdominal hypertension (IAH) is defined as the sustained increase in IAP above 12 mm of Hg and ACS as IAP above 20 mm of Hg with new‐onset organ failure with or without low abdominal perfusion pressure (APP). 15 However, even IAP less than 15 mm of Hg may cause organ dysfunction. 16 , 17
Massive fluid resuscitation in the early course of the disease, combined with the severe inflammatory process in the retroperitoneum, could contribute to visceral edema, leading to increased IAP. This acute increase of IAP in severe cases may lead to early organ dysfunction and ACS. 18 Paralytic ileus, upper gastrointestinal tract obstruction by pancreatic collection, and reduced abdominal wall compliance due to edema are other factors aggravating IAH in AP. 19
There are several studies reporting the incidence and consequences of IAH in intensive care patients, but in SAP, the literature is limited. The present study was undertaken to assess the significance of IAP in SAP and its relation to various other mortality indicators in AP.
Methods
All patients who were admitted to the Department of General Surgery and Medical Gastroenterology with diagnosis of SAP from July 2009 to December 2010 were enrolled in the study. A diagnosis of SAP was made based on revised Atlanta criteria in 2012. All patients with SAP who presented within 2 weeks from the onset of symptoms were included in the study. Patients who denied consent and who presented more than 2 weeks after the onset of symptoms were excluded.
The study is approved by the Institutional Ethics Committee as per institutional protocol.
Intra‐abdominal pressure
IAP was monitored by measuring intravesical pressure in the supine position at the end of expiration at a 4‐hourly interval by using Foleys catheter with a three‐way stop cock. IAP was measured on the day of admission to the hospital every 4 h, and the values of peak IAH were noted. A sustained increase in IAP was determined if at least three consecutive standardized measurements were elevated. Patients were divided into two groups (A and B) based on the absence and presence of IAH, respectively (IAH‐IAP >12 mm of Hg), based on the peak IAP values.
Management
All patients were managed according to the standard protocol, which included nasogastric decompression, intravenous fluids, analgesics, and other supportive measures. Antibiotic selection during the management was performed based on the evidence of sepsis and the availability of culture and sensitivity reports. Mechanical ventilation and vasopressor support were provided as and when indicated. Nutritional support was preferably enteral unless contraindicated. APACHE II score was calculated at admission. Organ failure during the first 7 days of admission was determined using SOFA score. Surgery was performed in the early period when other conservative measures to decrease IAH failed and at a later period in patients who did not respond to step up approach.
Statistical analysis
Descriptive statistics were used. Data were expressed as mean ± SD or mean (range) as appropriate. All statistical calculations were performed using the IBM Statistical Package for Social Sciences (SPSS) II version 22.0.0.0 software for Windows version 1.60. Nonparametric tests (Mann–Whitney U test) and linear regression analysis were used to evaluate ordinal data such as maximal IAP. The Chi square test was used for analysis of nominal data. Statistical significance was set as P < 0.05.
Results
Of the 35 patients included, 25 were males, and 10 were females. Etiology was alcohol in 19 (54.3%) patients, gall stone disease (GSD) in 10 (28.6%) patients, idiopathic disease in 4 patients, and hyperparathyroidism and endoscopic retrograde cholangio‐pancreatography (ERCP) in 1 patient each. The overall mortality was 22.85%. IAH was present in 51.4% (18/45) of the study population.
On comparison of demographics, etiology, modified CT severity index, various complications, and mortality, IAH was found to be higher in female and older patients, although this was not statistically significant. APACHE II score (Fig. 1), infectious complications, organ failure, and mortality were higher in patients with IAH (Tables 1 and 2). IAP of more than 20 mmHg was seen in three (8.5%) patients who eventually deteriorated. One of the three required percutenous drainage (PCD) for decompression but later succumbed to multiorgan failure; the remaining two patients required surgery—one for decompression and the other for infected necrosis. Both patients died eventually due to organ failure and septic shock, respectively.
Table 1.
Characteristics | IAH present (18) | IAH absent (17) | P value |
---|---|---|---|
Male | 10 (40%) | 15 (60%) | 0.060 |
Female | 8 (80%) | 2 (20%) | |
Gender ratio (Male: Female) | 1:1 | 3.5:1 | |
Age ± SD (in years) | 42.89 ± 13.86 | 31.59 ± 11.35 | 0.013 |
Table 2.
Characteristic | With IAH | Without IAH | P value |
---|---|---|---|
Total | 18 (51.4%) | 17 (48.6%) | |
Male | 10 | 15 | 0.06 |
Female | 8 | 2 | |
Age SD (in years) | 42.89 ± 13.86 | 31.59 ± 11.35 | 0.013 |
Etiology | |||
Alcohol | 6 | 13 | |
GSD | 7 | 3 | 0.089 |
Hyperparathyroidism | 1 | 0 | |
ERCP | 1 | 0 | |
Idiopathic | 4 | 1 | |
APACHE‐II | |||
<8 | 2 | 16 | <0.001 |
>8 | 16 | 1 | |
Modified CTSeverity Index (CTSI) | |||
7–8 | 13 | 17 | <0.001 |
>8 | 5 | 0 | |
Necrosis | |||
<50% | 13 | 16 | 0.117 |
>50% | 5 | 1 | |
CRP (mean ± SD) in mg/dL | 126.89 ± 45.3 | 54.12 ± 36.79 | <0.001 |
SOFA score (day 1–7) | |||
<5 | 0 | 10 | |
5–10 | 13 | 7 | <0.001 |
>10 | 5 | 0 | |
APACHE II (at Admission) | <0.001 | ||
<8 | 2 | 16 | |
>8 | 16 | 1 | |
Infections at admission | 1 | 0 | 0.34 |
Infections during hospitalization | 13 | 1 | <0.001 |
Organ failure | |||
Renal | 18 | 16 | 0.486 |
Cardiovascular | 16 | 0 | <0.001 |
Respiratory | 18 | 7 | <0.001 |
Mortality | 8 | 0 | 0.003 |
CRP, C reactive protein; CTSI, Computerised tomography severity index; ERCP, endoscopic retrograde cholangio‐pancreatography ; GSD, gall stone disease; IAH, intra‐abdominal hypertension.
Requirement of percutaneous drainage, total parenteral nutrition, and surgical management were found to be high in those patients with IAH. In addition to IAH, maximal IAP was also found to be in linear correlation with maximal SOFA score during the first week (Fig. 2), as well as in predicting the need for parenteral nutrition, surgery, and mortality during the hospital stay (Tables 3 and 4).
Table 3.
Management | With IAH | Without IAH | P value |
---|---|---|---|
PCD | 6 | 2 | 0.129 |
TPN | 9 | 0 | 0.001 |
Surgery | 5 | 0 | 0.019 |
Mortality | 8 | 0 | 0.003 |
Table 4.
Mean IAP ± 2SD (95% CI) | Maximum IAP ± 2SD (95% CI) | P value | |
---|---|---|---|
Parenteral Nutrition required | |||
Yes | 11.82 ± 1.75 | 15.56 ± 2.55 | 0.05 |
No | 9.32 ± 3.51 | 11.50 ± 4.07 | 0.016 |
PCD requirement | |||
Yes | 10.47 ± 1.35 | 13.25 ± 1.98 | 0.628 |
No | 9.81 ± 3.71 | 12.33 ± 4.57 | 0.588 |
Surgery | |||
Yes | 14.44 ± 4.97 | 17.80 ± 4.55 | <0.001 |
No | 9.22 ± 2.34 | 11.67 ± 3.38 | 0.008 |
Outcome | |||
Survivors | 8.74 ± 1.87 | 11.00 ± 2.74 | <0.001 |
Nonsurvivors | 14.07 ± 3.93 | 17.75 ± 3.77 | <0.001 |
CI, confidence interval.
Discussion
IAH is caused by several clinical conditions, for example, hemoperitoneum, bowel obstruction, intestinal edema, peritonitis, pelvic trauma, and surgery (aortic surgery and abdomen closure under tension). AP is one of the main causes of IAH of retroperitoneal origin. 20 , 21 , 22
According to the current definition of IAH, the reported incidence of IAH and ACS in AP is 60 and 27%, respectively. 22 , 23 , 24 , 25 , 26 In the present study, the incidence of IAH and ACS was 51.4 and 8.5%, respectively. Several mechanisms have been proposed for the development of IAH. Severe pancreatitis usually presents with an enlarged pancreas with inflammation and fluid collections in the retroperitoneum. In the beginning, it is localized, only to progress later to the whole retroperitoneum, including the root of mesentery. Necrosis further aggravates the problem. Other factors associated with SAP that contribute to IAH are ascites, visceral edema, ileus, and gastric dilatation due to collections or mechanical obstruction of the duodenum. Fluid resuscitation further plays an important role in the development of IAH due to capillary leakage as a result of a diffuse intra‐abdominal inflammatory process. IAH itself initiates a vicious cycle due to decreasing intestinal perfusion and compromised oxygen delivery. 27
Several studies established that infectious complications are higher in those patients who had IAH, reaching up to 60% in patients who had ACS. 23 , 28 , 29 , 30 The present study also confirms that infectious complications were very high (77.8%) in patients with IAH. Mean and maximal IAP were significantly higher in those patients who required surgery, as well those who died. Several prognostic factors, such as APACHE II, modified CTSI, CRP, and SOFA score were also found to be higher in the present study, which was comparable to the available evidence. 31 , 32 , 33 , 34 Ke et al. compared APP and IAP to determine severity and complications in AP and concluded that IAP is more valuable as an early measure for the evolution and complication of SAP. 33 Waele et al. studied the incidence of IAH and organ dysfunction in 44 (27 patients underwent IAP measurement) patients admitted in the ICU with diagnosis of SAP. Their result showed that IAH was frequently (78%) present and was associated with a high incidence of organ dysfunction, as well as high mortality. They suggested that the direct causal relationship between IAH and organ dysfunction was not proven in patients with SAP, and surgical decompression should not be routinely performed as it was associated with higher mortality. 35 Similarly, in the present study, the incidence of IAH was 51.4%, and ACS was found only in three patients; most of these patients were managed conservatively, and only two patients underwent surgical decompression in those three patients with ACS, and all three patients died. IAH is associated with organ dysfunction in AP, and to some extent, it is reversible and preventable through early management. This study advocates the need for frequent measurement of IAP at least every 4 h or whenever the clinical condition of the patient deteriorates to avoid unwanted outcomes such as IAH and ACS. Resuscitation in the early period of pancreatitis should judicious, and several recent trials showed that a combination of crystalloids and colloids is better than crystalloid alone to prevent IAH. 36 , 37 , 38 Several nonsurgical interventions have been tried to decrease IAP, such as nasogastric tube decompression, percutaneous drainage of intraperitoneal fluid, and neuromuscular blockers for the short term, which were reported to be beneficial. 39 , 40 Other interventions for removal of extra fluid by loop diuretics, extracorporeal technique, and hemodialysis have also been tried with variable outcomes. Loop diuretics should be used with caution because acute kidney injury is one of the first organ dysfunctions and may further accentuate renal failure. 27 In a recent study, Chen et al. found that a combination of nonsurgical interventions was able to reduce IAP in 7 of 20 patients with ACS and avoided decompressive laparotomy in each of them. 23 In the present study, one patient underwent percutaneous drainage for ACS; although IAP was decreased by 8 mmHg, the patient later succumbed to septic shock. Although surgery should be avoided in the early phase of SAP, few acute complications require early intervention, such as ACS not responding to conservative management, bowel ischemia, perforation, and severe bleeding not managed by radiological intervention. Several methods were used for surgical decompression, and the most common of these are midline laparotomy followed by bilateral subcostal incision for full‐thickness laparotomy and short horizontal skin incision to perform subcutaneous linea alba fasciotomy (SLAP) with the peritoneum left intact. 41 , 42 , 43 All these methods have been shown to have variable outcome. In the present study, three (8.5%) patient with ACS required intervention. One underwent percutaneous drainage for decompression, and the remaining two patients underwent laparotomy for decompression and infected necrosis, respectively. In spite of interventions, these three patients could not be saved.
Limitations
A small sample size, the lack of information regarding the role of fluid resuscitation, and the effect of decompression in modulating the course of SAP that were not within the purview of this study were the probable limitations of this study. A multivariate analysis was also not performed.
In summary, our study, in accordance with other studies, shows that increased IAP is common in SAP and is significantly correlated with the various other indicators of severity in SAP. The overall incidence of IAH in SAP was around 51.4%. It also has a negative impact on the outcome of the disease in terms of increased mortality and morbidity, along with the increase in the requirement of hospital stay and intensive care support. In fact, all the patients who succumbed in this study had evidence of IAH. It is thus necessary to measure IAP routinely as it is an important parameter associated with the course, management, and outcome of SAP.
Declaration of conflict of interest: We declare that there are no conflicts of interest.
References
- 1. Banks PA, Bollen TL, Dervenis C et al Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013; 62: 102–11. [DOI] [PubMed] [Google Scholar]
- 2. Phillip V, Steiner JM, Algül H. Early phase of acute pancreatitis: assessment and management. World J. Gastrointest. Pathophysiol. 2014; 5: 158–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Nieminen A, Maksimow M, Mentula P et al Circulating cytokines in predicting development of severe acute pancreatitis. Crit. Care. 2014; 18: 104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Halonen KI, Leppaniemi AK, Puolakkainen PA et al Severe acute pancreatitis: prognostic factors in 270 consecutive patients. Pancreas. 2000; 21: 266–71. [DOI] [PubMed] [Google Scholar]
- 5. Gloor B, Müller CA, Worni M, Martignoni ME, Uhl W, Büchler MW. Late mortality in patients with severe acute pancreatitis. Br. J. Surg. 2001; 88: 975–9. [DOI] [PubMed] [Google Scholar]
- 6. McKay CJ, Buter A. Natural history of organ failure in acute pancreatitis. Pancreatology. 2003; 3: 111–14. [DOI] [PubMed] [Google Scholar]
- 7. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J. Pathol. 2000; 190: 117–25. [DOI] [PubMed] [Google Scholar]
- 8. Bhatia M, Fei LW, Cao Y et al Pathophysiology of acute pancreatitis. Pancreatology. 2005; 5: 132–44. [DOI] [PubMed] [Google Scholar]
- 9. McKay CJ, Imrie CW. The continuing challenge of early mortality in acute pancreatitis. Br. J. Surg. 2004; 91: 1243–4. [DOI] [PubMed] [Google Scholar]
- 10. Renner IG, Savage WT, Pantoja JL, Renner VJ. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig. Dis. Sci. 1985; 30: 1005–18. [DOI] [PubMed] [Google Scholar]
- 11. Widdison AL, Karanjia ND. Pancreatic infection complicating acute pancreatitis. Br. J. Surg. 1993; 80: 148–54. [DOI] [PubMed] [Google Scholar]
- 12. Wang ZF, Pan CE, Lu Y, Zhang SG, Zhang XB. The role of inflammatory mediators in acute severe pancreatitis and regulation of glucocorticoids. HBPD Int. 2003; 2: 458–62. [PubMed] [Google Scholar]
- 13. Sanchez NC, Tenofsky PL, Dort JM, Shen LY, Helmer SD, Smith RS. What is normal intra‐abdominal pressure? Am. Surg. 2001; 67: 243–8. [PubMed] [Google Scholar]
- 14. Cheatham ML, De Waele J, Kirkpatrick A et al Criteria for a diagnosis of abdominal compartment syndrome. Can. J. Surg. 2009; 52: 315–16. [PMC free article] [PubMed] [Google Scholar]
- 15. Cheatham ML, Malbrain ML, Kirkpatrick A et al Results from the international conference of experts on intra‐abdominal hypertension and abdominal compartment syndrome. II. Recommendations. Intensive Care Med. 2007; 33: 951–62. [DOI] [PubMed] [Google Scholar]
- 16. Schwarte LA, Scheeren TW, Lorenz C, De Bruyne F, Fournell A. Moderate increase in intraabdominal pressure attenuates gastric mucosal oxygen saturation in patients undergoing laparoscopy. Anesthesiology. 2004; 100: 1081–7. [DOI] [PubMed] [Google Scholar]
- 17. Malbrain ML. Is it wise not to think about intraabdominal hypertension in the ICU? Curr. Opin. Crit. Care. 2004;10:132–45. [DOI] [PubMed] [Google Scholar]
- 18. Wilmer A. ICU management of severe acute pancreatitis. Eur. J. Intern. Med. 2004; 15: 274–80. [DOI] [PubMed] [Google Scholar]
- 19. Nathens AB, Curtis JR, Beale RJ et al Management of the critically ill patient with severe acute pancreatitis. Crit. Care Med. 2004; 32: 2524–36. [DOI] [PubMed] [Google Scholar]
- 20. Saggi BH, Sugerman HJ, Ivatury RR, Bloomfield GL. Abdominal compartment syndrome. J. Trauma. 1998; 45: 597–609. [DOI] [PubMed] [Google Scholar]
- 21. De Waele JJ, De Laet I, Malbrain ML. Rational intraabdominal pressure monitoring: how to do it? Acta Clin. Belg. 2007; 62 (Suppl. 1): 16–25. [DOI] [PubMed] [Google Scholar]
- 22. Pupelis G, Austrums E, Snippe K, Berzins M. Clinical significance of increased intraabdominal pressure in severe acute pancreatitis. Acta Chir. Belg. 2002; 102: 71–4. [DOI] [PubMed] [Google Scholar]
- 23. Chen H, Li F, Sun JB, Jia JG. Abdominal compartment syndrome in patients with severe acute pancreatitis in early stage. World J. Gastroenterol. 2008; 14: 3541–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Al‐Bahrani AZ, Abid GH, Holt A et al Clinical relevance of intra‐abdominal hypertension in patients with severe acute pancreatitis. Pancreas. 2008; 36: 39–43. [DOI] [PubMed] [Google Scholar]
- 25. Malbrain ML, Cheatham ML, Kirkpatrick A et al Results from the international conference of experts on intra‐abdominal hypertension and abdominal compartment syndrome. I. Definitions. Intensive Care Med. 2006; 32: 1722–32. [DOI] [PubMed] [Google Scholar]
- 26. Keskinen P, Leppaniemi A, Pettila V, Piilonen A, Kemppainen E, Hynninen M. Intra‐abdominal pressure in severe acute pancreatitis. World J. Emerg. Surg. 2007; 2: 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. De Waele JJ, Leppäniemi AK. Intra‐abdominal hypertension in acute pancreatitis. World J. Surg. 2009; 33: 1128–33. [DOI] [PubMed] [Google Scholar]
- 28. Diebel LN, Dulchavsky SA, Brown WJ. Splanchnic ischemia and bacterial translocation in the abdominal compartment syndrome. J. Trauma. 1997; 43: 852–5. [DOI] [PubMed] [Google Scholar]
- 29. Rosas JM, Soto SN, Aracil JS et al Intra‐abdominal pressure as a marker of severity in acute pancreatitis. Surgery. 2007; 141: 173–8. [DOI] [PubMed] [Google Scholar]
- 30. De Waele J, Vogelaers D, Decruyenaere J, De Vos M, Colardyn F. Infectious complications of acute pancreatitis. Acta Clin. Belg. 2004; 59: 90–6. [DOI] [PubMed] [Google Scholar]
- 31. Khan AA, Parekh D, Cho Y et al Improved prediction of outcome in patients with severe acute pancreatitis by the APACHE II score at 48 hours after hospital admission compared with the APACHE II score at admission; Acute Physiology and Chronic Health Evaluation. Arch. Surg. 2002; 137: 1136–40. [DOI] [PubMed] [Google Scholar]
- 32. Eachempati SR, Hydo LJ, Barie PS. Severity scoring for prognostication in patients with severe acute pancreatitis: comparative analysis of the Ranson score and the APACHE III score. Arch. Surg. 2002; 137: 730–6. [DOI] [PubMed] [Google Scholar]
- 33. Ke L, Ni HB, Tong ZH, Li WQ, Li N, Li JS. Intra‐abdominal pressure and abdominal perfusion pressure: which is a better marker of severity in patients with severe acute pancreatitis. J. Gastrointest. Surg. 2011; 15: 1426–32. [DOI] [PubMed] [Google Scholar]
- 34. Singh RK, Poddar B, Baronia AK et al Audit of patients with severe acute pancreatitis admitted to an intensive care unit. Indian J. Gastroenterol. 2012; 31: 243–52. [DOI] [PubMed] [Google Scholar]
- 35. De Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F. Intra‐abdominal hypertension in patients with severe acute pancreatitis. Crit. Care. 2005; 9: R452–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Mao EQ, Fei J, Peng YB, Huang J, Tang YQ, Zhang SD. Rapid hemodilution is associated with increased sepsis and mortality among patients with severe acute pancreatitis. Chin. Med. J. 2010; 123: 1639–44. [PubMed] [Google Scholar]
- 37. Mao EQ, Tang YQ, Fei J et al Fluid therapy for severe acute pancreatitis in acute response stage. Chin. Med. J. 2009; 122: 169–73. [PubMed] [Google Scholar]
- 38. Zhao G, Zhang JG, Wu HS et al Effects of different resuscitation fluid on severe acute pancreatitis. World J. Gastroenterol. 2013; 19: 2044–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Sun ZX, Huang HR, Zhou H. Indwelling catheter and conservative measures in the treatment of abdominal compartment syndrome in fulminant acute pancreatitis. World J. Gastroenterol. 2006; 12: 5068–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. De Laet I, Hoste E, Verholen E, De Waele JJ. The effect of neuromuscular blockers in patients with intra‐abdominal hypertension. Intensive Care Med. 2007; 33: 1811–4. [DOI] [PubMed] [Google Scholar]
- 41. De Waele JJ, Hoste EA, Malbrain ML. Decompressive laparotomy for abdominal compartment syndrome ‐ a critical analysis. Crit. Care. 2006; 10: R51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Leppäniemi A, Mentula P, Hienonen P, Kemppainen E. Transverse laparostomy is feasible and effective in the treatment of abdominal compartment syndrome in severe acute pancreatitis. World J. Emerg. Surg. 2008; 3: 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Leppäniemi AK, Hienonen PA, Siren JE, Kuitunen AH, Lindström OK, Kemppainen EA. Treatment of abdominal compartment syndrome with subcutaneous anterior abdominal fasciotomy in severe acute pancreatitis. World J. Surg. 2006; 30: 1922–4. [DOI] [PubMed] [Google Scholar]